Nick Verheyen

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Dirk Roymans, Sarhad Alnajjar, Michael B. Battles et al. · Nature Communications · 2017 · 97 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

Dirk Roymans, Hendrik L. De Bondt, Éric Arnoult et al. · Proceedings of the National Academy of Sciences · 2009 · 90 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Structural and mechanistic insights into the inhibition of respiratory syncytial virus polymerase by a non-nucleoside inhibitor

Xiaodi Yu, Pravien Abeywickrema, Brecht Bonneux et al. · Communications Biology · 2023 · 37 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library

Ilane Hernández‐Morales, Peggy Geluykens, Marleen Clynhens et al. · Antiviral Research · 2017 · 25 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

A truncated HIV Tat demonstrates potent and specific latency reversal activity

Ellen Van Gulck, Marion Pardons, Erik Nijs et al. · Antimicrobial Agents and Chemotherapy · 2023 · 15 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14